Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT05507372
Other study ID # JW-COVID-DRG-001
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date October 1, 2022
Est. completion date December 1, 2023

Study information

Verified date August 2022
Source Applied Biology, Inc.
Contact Andy Goren, MD
Phone 6507040850
Email andyg@appliedbiology.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Post-acute COVID-19 tinnitus has not been treated successfully. As tinnitus may be related to SARS-CoV-2 neurological manifestations. This study aims to investigate if the dopamine receptor antagonists can be used effectively treat COVID-19 induced tinnitus.


Description:

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative viral pathogen leading to the COVID-19 pandemic. In 2022, after three successive waves of the pandemic, the majority of the human population has been exposed to the SARS-CoV-2 virus. During the two years since the pandemic ensued, multiple reports emerged of patients experiencing COVID-19 emergent symptoms lasting longer than 4 weeks since onset. Up to 15% of patients recovering from COVID-19 experience post-acute COVID-19 induced tinnitus . To-date, post-acute COVID-19 tinnitus has not been treated successfully. As tinnitus may be related to SARS-CoV-2 neurological manifestations. This study aims to investigate if the dopamine receptor antagonist Pimozide can be used effectively treat COVID-19 induced tinnitus.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 50
Est. completion date December 1, 2023
Est. primary completion date June 1, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: 1. Diagnosed with subjective tinnitus post COVID-19 2. Tinnitus persists for at least 4 weeks 3. Prior history of mild or no tinnitus 4. 18 years or older 5. Any gender 6. Females of child bearing age must be on contraception Exclusion Criteria: 1. Pregnant 2. Patients who participated in any interventional studies in the past 6 months 3. Patients with severe hepatic impairment on admission (alanine aminotransferase higher than fivefold the upper limit) 4. Patients taking any dopamine receptor antagonists 5. Patient having history of hypersensitivity to Pimozide 6. Patients unable to comply with the study schedule 7. Actively using cortiocosteroids

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Pimozide 1 MG
Dopamine Receptor Antagonist - Oral Pimozide

Locations

Country Name City State
n/a

Sponsors (2)

Lead Sponsor Collaborator
Applied Biology, Inc. Jupiter Wellness, Inc.

Outcome

Type Measure Description Time frame Safety issue
Primary Tinnitus Handicap Inventory (THI) The Tinnitus Handicap Inventory Scale is between 0-100. And is stratified to Grades between 1-5. A higher grades means more severe handicap from tinnitus. 4 weeks
See also
  Status Clinical Trial Phase
Recruiting NCT04987502 - Virtual Reality and Subjective Tinnitus N/A
Completed NCT04281953 - Impact on Quality of Life of Long-term Ototoxicity in Cancer Survivors
Recruiting NCT04404439 - Treatment of Tinnitus With Migraine Medications Phase 4
Completed NCT03782220 - Effects of Kinesio Taping in Patients With Somatosensory Tinnitus N/A
Completed NCT05711641 - Action of Intra-auricular Topical Lidocaine on Tinnitus N/A
Completed NCT03711630 - Impact of Meditation on Bothersome Tinnitus N/A
Completed NCT05591144 - Short-term Oral Prednisone for Acute Subjective Tinnitus N/A
Completed NCT04565132 - HD-tDCS as a Treatment for Chronic Tinnitus N/A
Completed NCT02315508 - Evaluating Possible Improvement in Tinnitus Severity After 28 Days Dosing of the Study Drug AUT00063 Compared to Placebo Phase 2
Active, not recruiting NCT03888521 - Evaluating the GN ReSound Relief App Using task-and Rest-based fMRI N/A
Recruiting NCT05198973 - Bumblebee Breath Effect on Tinnitus in Older Patients N/A
Not yet recruiting NCT04623957 - Safety and Efficacy of Acupressure Applied Through ForgTin© in Patients With Tinnitus N/A
Recruiting NCT05964725 - The Study on Effect and Neural Network Mechanism of Transcranial Direct Current Stimulation for Sudden Deafness With Tinnitus N/A
Not yet recruiting NCT05417711 - Efficacy of Transcutaneous Vagus Nerve Stimulation Paired With Tailor-Made Notched Music Therapy Versus Tailor-made Notched Music Training for Chronic Subjective Tinnitus N/A
Recruiting NCT04162405 - Tinnitus in Patients With and Without Sensorineural Hearing Loss
Completed NCT03716544 - Efficacy of Amplification With Hearing Aids for Tinnitus Relief N/A
Completed NCT03638986 - Comparison of the Two Validated German Versions of the "Tinnitus Functional Index" for Switzerland and for Germany
Completed NCT04127708 - Tinnitus and Acupuncture N/A
Not yet recruiting NCT06433895 - Efficacy of Manual Therapy in the Treatment of Somatic Tinnitus N/A
Enrolling by invitation NCT04382807 - Internet-delivered Group Counseling for Chronic Tinnitus